Ranibizumab ophthalmic and Zohydro ER
Determining the interaction of Ranibizumab ophthalmic and Zohydro ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: hydrocodone
Brand name: Zohydro ER, Hysingla ER, Vantrela ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Zohydro ER Capsules
- Ranibizumab ophthalmic-Zoladex
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 10.8 mg)
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 3.6 mg)
- Ranibizumab ophthalmic-Zoladex 3-Month
- Ranibizumab ophthalmic-Zoladex Implant
- Zohydro ER-Ranitidine
- Zohydro ER-Ranitidine Capsule
- Zohydro ER-Ranitidine Hydrochloride
- Zohydro ER-Ranitidine Injection
- Zohydro ER-Ranitidine Suspension
- Zohydro ER-Ranitidine Syrup